TrianglePUBLICATIONS · 21108851
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Hematol Oncol
- Publication date
- 2010 Nov 26
- First author
- Wei G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wei G
- type
- Author
- name
- Rafiyath S
- type
- Author
- name
- Liu D
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wei G
- type
- Author
- name
- Rafiyath S
- type
- Author
- name
- Liu D
- type
- Author
- bibliography ids
- nci-bib-73e497886485826083a528bf
- book metadata
- content sha256
- 24b42b7f1858e582a4bfae0a001cafe19a6b302e1182c46faf5ffcaa29836eb8
- document type
- citation
- dois
- 10.1186/1756-8722-3-47
- electronic publication date
- display
- 2010 Nov 26
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21108851
- immutable id
- pubmed:21108851@24b42b7f1858e582a4bfae0a001cafe19a6b302e1182c46faf5ffcaa29836eb8
- journal
- abbreviation
- J Hematol Oncol
- issn electronic
- 1756-8722
- issn print
- Source null
- issue
- Source null
- name
- Journal of hematology & oncology
- nlm unique id
- 101468937
- pages
- 47
- volume
- 3
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21108851
- provenance
- batch id
- edef4b7f1a2a505cd5a9
- provider
- NCBI PubMed ESummary
- record sha256
- fa13b1d92cebee5ce609a0e8b3626d87b49072e618363f54bcb5641dec35093a
- response sha256
- d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
- retrieved at
- 2026-09-09T23:46:38.027615+00:00
- publication date
- display
- 2010 Nov 26
- precision
- day
- year
- 2010
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.
Preserved source evidence · Not medical advice